Sign in

Mete Ercis

@kideyda.bsky.social
52 followers 74 following 12 posts

Post-doc. Psychiatrist.

PostsRepliesMedia
Mete Ercis @kideyda.bsky.social · 02/10/2026
Excited to share our new paper in Translational Psychiatry! 🧠 Using a targeted multi-omic approach, we found that higher kynurenic acid (both genetically 🧬PGS-KYNA and in 🧪serum) was associated with better lithium response in #BipolarDisorder. 🔓 rdcu.be/EEQuK9eN8E1a
rdcu.be
000
Mete Ercis @kideyda.bsky.social · 10/06/2026
✨Excited to share our new publication in Bipolar Disorders! Using data from the Mayo Clinic BD Biobank, we found that family history 👨‍👩‍👧 and polygenic risk scores 🧬 may provide independent and complementary information for predicting lithium response. 📄 doi.org/10.1111/bdi....
doi.org
000
Mete Ercis @kideyda.bsky.social · 02/05/2026
Does bipolar II deserve a new name 🏷️? In our new Insight in European Neuropsychopharmacology, we argue yes. BD-II is distinct in phenomenology 🧠, illness course 📈, genetics 🧬, and treatment response 💊. Renaming could shift the paradigm 🔄 & improve care ✨ 🔗 authors.elsevier.com/c/1n1Q4,L21E...
authors.elsevier.com
Please wait whilst we redirect you
All content on this site: Copyright © 2026 Elsevier B.V., its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
010
Mete Ercis @kideyda.bsky.social · 02/03/2026
Excited about our latest publication in Bipolar Disorders! 🎉 SGLT2 inhibitors were associated with improved kidney function trajectories in lithium-treated patients 💊📈 Grateful to all collaborators! 🔗 onlinelibrary.wiley.com/doi/epdf/10....
onlinelibrary.wiley.com
SGLT2 Inhibitors Associated With Improved Kidney Function in Lithium‐Treated Patients With Mood Disorders: A Real‐World Historical Cohort Study
Introduction Sodium-glucose cotransporter-2 inhibitors (SGLT2i), initially developed for type 2 diabetes, have shown promise in improving renal outcomes in patients with and without diabetes. Howeve...
000
Reposted by Mete Ercis
Eiko Fried @eikofried.bsky.social · 12/01/2026
Our machine learning competition on forecasting depression is online! We'd love for as many people as possible to participate. Please share in your respective networks — thank you :). www.staff.universiteitleiden.nl/announcement...
staff.universiteitleiden.nl
Machine-learning competition on forecasting depression in young adults - Leiden University
After nearly 5 years of work, the research team led by Eiko Fried has finished data collection in the ERC-funded WARN-D project on building a personalised early warning system for depression. But just...
03926
Mete Ercis @kideyda.bsky.social · 18/11/2025
📢 Our new systematic review & meta-analysis is out! Across 50 studies, we examined the prevalence of dermatologic side effects 📊 of mood stabilizers 💊 in bipolar disorder. 🔍 Full text: doi.org/10.1016/j.jp...
000
Mete Ercis @kideyda.bsky.social · 23/06/2025
Are there unique pathways leading to a first episode of mania or psychosis? 🔍 Using latent class analysis, we identified 3 distinct antecedent trajectories. 📄 PDF: onlinelibrary.wiley.com/share/author... 🔗 Link: doi.org/10.1111/acps... 👇
onlinelibrary.wiley.com
110
Mete Ercis @kideyda.bsky.social · 20/06/2025
Does mental health shape cancer outcomes? 🧠🎀 We studied how bipolar disorder affects breast cancer diagnosis & outcomes, focusing on genetic risk 🧬 and lifestyle 🏃‍♀️🍷🍔. Grateful to lead this effort and work with such an incredible team! 🔗 authors.elsevier.com/c/1lIHJ_3mNQ...
authors.elsevier.com
000
Mete Ercis @kideyda.bsky.social · 29/05/2025
Thrilled to share our findings at #APAAM2025 in LA! Seasonality Linked to Different Bipolar Features and Treatment Response 🌸☀️🍂❄️ Presented on behalf of Siralp Bostan, MD — with tremendous contributions from Lindsay Melhuish, PhD. Great team effort! 📰 www.medscape.com/viewarticle/...
medscape.com
Seasonality Linked to Different Bipolar Features
Subtypes of seasonality are associated with varying characteristics of bipolar disorder and with response to treatments such as lithium, a new study suggests.
010
Mete Ercis @kideyda.bsky.social · 03/01/2025
Our commentary/mini review on Lithium and Kidney Disease (doi.org/10.1016/j.ma...) is just published in Mayo Clinic Proceedings! We discuss key risk factors🩺, controversies📊, and challenges surrounding discontinuing lithium⚖️. A glance at 📺: youtu.be/aiUHRfGNn50?...
doi.org
Redirecting
031